Insider Returns Down To US$14k As enGene Holdings' Stock Dips 11%

Insiders who bought enGene Holdings Inc. (NASDAQ:ENGN) in the last 12 months may probably not pay attention to the stock's recent 11% drop. Even after accounting for the recent loss, the US$57.0k worth of stock purchased by them is now worth US$71.4k or in other words, their investment continues to give good returns.

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.

View our latest analysis for enGene Holdings

The Last 12 Months Of Insider Transactions At enGene Holdings

In the last twelve months, the biggest single purchase by an insider was when Chief Executive Officer & Director Ronald H. Cooper bought US$57k worth of shares at a price of US$5.70 per share. We do like to see buying, but this purchase was made at well below the current price of US$7.14. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.

The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.

Does enGene Holdings Boast High Insider Ownership?

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Our data suggests enGene Holdings insiders own 0.4% of the company, worth about US$1.5m. We consider this fairly low insider ownership.

So What Do The enGene Holdings Insider Transactions Indicate?

It doesn't really mean much that no insider has traded enGene Holdings shares in the last quarter. But insiders have shown more of an appetite for the stock, over the last year. The transactions are fine but it'd be more encouraging if enGene Holdings insiders bought more shares in the company. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. For instance, we've identified 3 warning signs for enGene Holdings (2 are significant) you should be aware of.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.